Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence
Abstract
Objectives To measure the burden of disease and describe the epidemiology of cryptococcosis in Gauteng Province, South Africa. Design and methods The study was an active, prospective, laboratory-based, population-based surveillance. An incident case of cryptococcosis was defined as the first isolation by culture of any Cryptococcus species from any clinical specimen, a positive India ink cryptococcal latex agglutination test or a positive histopathology specimen from a Gauteng resident. Cases were identified prospectively at all laboratories in Gauteng. Case report forms were completed using medical record review and patient interview where possible. Results Between 1 March 2002 and 29 February 2004, 2753 incident cases were identified. The overall incidence rate was 15.6/100 000. Among HIV-infected persons, the rate was 95/100 000, and among persons living with AIDS 14/1000. Males and children under 15 years accounted for 49 and 0.9% of cases, respectively. The median age was 34 years (range, 1 month-74 years). Almost all cases (97%) presented with meningitis. Antifungal therapy was given to 2460 (89%) cases of which 72% received fluconazole only. In-hospital mortality was 27% (749 cases). Recurrences occurred in 263 (9.5%) incident cases. Factors associated with death included altered mental status, coma or wasting; factors associated with survival included employment in the mining industry, visual changes or headache on presentation. Conclusions This study demonstrates the…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Among undifferentiated patients with pneumonia or sepsis, broad-spectrum regimens including agents active against MRSA were associated with higher mortality, particularly among patients without MRSA.
“Among undifferentiated patients with pneumonia or sepsis, broad-spectrum regimens including agents active against MRSA were associated with higher mortality, particularly among patients without MRSA (137,151,155,156).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [137]
The incidence of MRSA varies by region (ranging from ~2% in Western Europe to 10% in North America) and by patient-related characteristics.
“The incidence of MRSA varies, however, by region (ranging from ~2% in Western Europe to 10% in North America) and by patient-related characteristics (133, 136, 137).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [137]
The citation lists haven’t been fetched yet
References 33 · Cited by 115
- Authors
- McCarthy, K. M., Morgan, J., Wannemuehler, K. A., Mirza, S. A., Gould, S. M., Mhlongo, N., Moeng, P., Maloba, B. R., Crewe-Brown, H. H., Brandt, M. E., & Hajjeh, R. A.
- Affiliations
- National Health Laboratory Service (ZA)
- Centers for Disease Control and Prevention (US)
- Corresponding author
- McCarthy, Kerrigan M
- Venue
- AIDS
- Published
- 2006-11-14
- Volume
- 20
- Issue
- 17
- Pages
- 2199-2206
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2058787796
- Cited by
- 115
- References
- 33
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 17 · 2013: 10 · 2012: 7
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
- Keywords
- cryptococcosis, Cryptococcus, HIV, cryptococcal meningitis, incidence, disease burden, antifungal therapy, fluconazole, mortality, recurrence, risk factors, Gauteng
- MeSH terms
- Adolescent, Adult, Aged, Antifungal Agents, Child, Child, Preschool, Cryptococcosis, Humans, Infant, Middle Aged, Population Surveillance, Recurrence, South Africa, HIV Seroprevalence, Incidence, Treatment Outcome, Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review